Cannabics PharmaceuticalsCNBX 
$0.010.00%24h
0.00%24h
Global rank
Market cap$88.25K
Change 7d0.00%
YTD Performance0.00%
SP500 benchmarkUnderperform
P/E-0.02
P/S0.22
Revenue$410.17K
Earnings-$3.71M
Dividend yield-
Main Sector
Healthcare
Category
Cannabics Pharmaceuticals (CNBX) Total Liabilities
CNBX Total Liabilities in 2022: $2.52M
According to Cannabics Pharmaceuticals latest financial reports the total liabilities of CNBX is $2.52M, an increase of 2.98% to 2022. At the end of 2022 company had $2.44M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Cannabics Pharmaceuticals is responsible for during its operational activities.
Cannabics Pharmaceuticals (CNBX) Total Liabilities History from 2023 to 2022
-
Value:-
CNBX Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $2.52M | 2.98% |
| 2022 | $2.44M | 91.94% |
| 2021 | $1.27M | 179.92% |
| 2020 | $454.79K | 3.63% |
| 2019 | $438.87K | 39.00% |
| 2018 | $315.74K | - |
View the Top Total Liabilies Stocks
